Company Filing History:
Years Active: 2025
Title: Sven Breunig: Innovator in SARS-CoV-2 Detection
Introduction
Sven Breunig is a notable inventor based in Seekirchen am Wallersee, Austria. He has made significant contributions to the field of biotechnology, particularly in the detection of SARS-CoV-2 mutants. His innovative work has implications for public health and disease management.
Latest Patents
Sven Breunig holds a patent for "Assays for the detection of SARS-CoV-2 mutants." This patent involves an oligonucleotide that is detectably labeled and has a specific nucleotide sequence. The sequences include various identifiers such as SEQ ID NO:5, SEQ ID NO:6, and others, which are crucial for accurate detection of the virus.
Career Highlights
Sven is currently employed at Procomcure Biotech GmbH, where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in biotechnology, particularly in the context of viral detection and diagnostics.
Collaborations
Sven collaborates with Kamil Önder, a fellow researcher, to further enhance the capabilities of their projects. Their teamwork exemplifies the importance of collaboration in scientific research and innovation.
Conclusion
Sven Breunig's contributions to the field of biotechnology, particularly in the detection of SARS-CoV-2, highlight his role as an important inventor. His work not only advances scientific knowledge but also has practical applications in public health.